Navigation Links
Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
Date:5/28/2008

ard of Directors of the American Society of

Clinical Oncology and the American Association of Cancer Institutes. He

is past chair of ASCO's Cancer Research Committee and of the Cancer

Communications Committee. He is the author of many scientific

publications and has served on the editorial boards of the

International Journal of Gynecologic Cancer, International Journal of

Oncology, Cancer Research, Cancer Investigation, Journal of

Experimental Therapeutics and Oncology and Clinical Cancer Research. He

earned his bachelor's degree in chemistry, Ph.D. and M.D. from the

University of Rochester. He completed his medical training at

Dartmouth-Hitchcock Medical Center and a medical oncology fellowship at

the National Cancer Institute.

-- Everett E. Vokes, M.D., is the John E. Ultmann Professor of Medicine

and Radiation and Cellular Oncology at the University of Chicago

Pritzker School of Medicine; director of the Section of

Hematology/Oncology; vice chairman for clinical research in the

Department of Medicine; director of the head and neck oncology program;

and deputy director of the University of Chicago Cancer Research

Center. He serves as chair of the Cancer and Leukemia Group B,

Respiratory Core Committee. He is the recipient of numerous research

grants and has authored more than 300 publications in peer-reviewed

journals. He received his medical degree from the University of Bonn

Medical School in West Germany and completed his residency at

Ravenswood Hospital in Chicago and at the University of Southern

California in Los Angeles. He completed a fellowship in

hematology/oncology at the University of Chicago.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and comme
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Poniard Pharmaceuticals Reports First Quarter 2008 Financial Results and Corporate Update
2. Poniard Pharmaceuticals Announces Upcoming Conference Participation
3. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
4. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
5. Poniard Pharmaceuticals Announces Upgrade of Stock Listing to NASDAQ Global Market
6. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
7. XTL Biopharmaceuticals Announces Appointment of Laurence N. Charney to Board of Directors
8. Sonus Pharmaceuticals and OncoGenex Technologies to Merge
9. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
10. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
11. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing ... - Europe Version" report to their offering. ... area of molecular diagnostics and pharmacogenics hold the ... market that is moving out of the national ...
(Date:5/5/2015)... College Station, TX (PRWEB) May 05, 2015 ... Pfizer were announced last week as recipients of ... Technology Innovation in recognition of their Portable, Continuous, ... system that integrates a small footprint, continuous processing ... GMP modules) to process API powders and inactive ...
(Date:5/4/2015)... , May 4, 2015 Tobira Therapeutics, ... on the development and commercialization of novel treatments ... completion of its merger with Regado Biosciences, Inc. ... the closing of the merger, Tobira raised $40 ... new investors and all current Tobira institutional investors, ...
(Date:5/4/2015)... N.Y. , May 4, 2015  Traverse ... $250,000 cooperative research and development agreement (CRADA) with ... advance the development of TRB-N0224 for the treatment ... including dogs and cats.  Traverse Biosciences has also ... for the treatment and control of periodontal disease ...
Breaking Biology Technology:European Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market 2015-2019 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 2Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 3Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 4Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 5Tobira Therapeutics Completes Financing and Merger with Regado Biosciences 6Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 2Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 3Traverse Biosciences Executes Agreement with Aratana Therapeutics to Advance Development of TRB-N0224 for the Treatment and Control of Periodontal Disease in Pets 4
... and Taq DNA Polymerases ,,,, pfuturbo DNA ... amplification , , Holly Hogrefe ... this update, we compare the PCR performances of ... polymerase. ,PCR product yields were higher (>3-kb ...
... Over 145,000 human cDNA clones arrayed for nucleic acid screening , ... de Leon Bruce Jerpseth , ... Stratagene has organized over 145,000 high-quality clones from a universal ... in 29 different human tissues. , This ...
... for Eagle Eye II still video system ... Coomassie ,Brilliant Blue Dye , Michelle Cayouette ... provides an optical bandpass filter with all Eagle,Eye ... visualizing,ethidium bromide fluorescence. However, a single filter specifically designed,for ...
Cached Biology Technology:PCR Performance Comparisons Between pfuturbo and Taq DNA,Polymerases 2PCR Performance Comparisons Between pfuturbo and Taq DNA,Polymerases 3PCR Performance Comparisons Between pfuturbo and Taq DNA,Polymerases 4Human Universal cDNA Library Array I 2Human Universal cDNA Library Array I 3Human Universal cDNA Library Array I 4Human Universal cDNA Library Array I 5Human Universal cDNA Library Array I 6Human Universal cDNA Library Array I 7Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 2Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 3Optimized Imaging of Protein Gels Stained with Coomassie,Brilliant Blue Dye 4
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:3/31/2015)...   Guidepoint , a leading global research services ... Management TRACKER, part of the Guidepoint TRACKER ... medical device and therapeutics markets. The Post-Surgical Pain Management ... market share, and adoption rates across three major modalities ... The Post-Surgical Pain Management TRACKER will provide ...
(Date:3/24/2015)... WASHINGTON , March 24, 2015   NexID ... applications with critical security-authentication needs, today announced the beginning ... fake-finger-detection (FFD) solution. The company, based in ... announcement at the three-day Connect:ID Expo, which began here ... NexID said version 2.0 of its SDK boosts ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... representatives of the tropical fish known as swordtail characins have ... on a fishing rod would. What,s more, a study reported ... Cell Press publication, shows just what any good fly-fisherman would ... fish most often eat. For some characins in the study, ...
... release is available in German . , It ... defects. This is because the development of the heart in the ... also error-prone. Scientists from the Max Planck Institute for Heart and ... that plays a central role in regulating the function of stem ...
... commonly used to convert chemical energy to electricity is made ... University argues. Rather than continue the futile effort to tweak ... Chemistry Professor Alfred Anderson urges his colleagues to start anew. ... system," he said. Anderson freely acknowledges he doesn,t know what ...
Cached Biology News:Male sex ornaments are fishing lures, literally 2Finished heart switches stem cells off 2Finished heart switches stem cells off 3Platinum is wrong stuff for fuel cells 2
... tumor cells of embryonal carcinoma of testis and ... tumors like seminoma. Glandular epithelium of yolk sac ... endocrine cells of stomach and acini cells of ... Epitope: Carbohydrate portion on human embryonal ...
TP-1 (NDOG1)...
Ras-related C3 botulinum toxin substrate 1...
Mouse monoclonal [6G11] to Cytohesin 1 + 2 ( Abpromise for all tested applications)....
Biology Products: